Top

Journal of Cardiovascular Translational Research

Published in:

01-04-2014

Devices for Mitral Valve Repair

Authors: Paolo Denti, Francesco Maisano, Ottavio Alfieri

Published in: Journal of Cardiovascular Translational Research | Issue 3/2014

Abstract

The natural history of severe mitral regurgitation (MR) is unfavorable, leading to left ventricular failure, atrial fibrillation, stroke, and death. Many patients affected by severe regurgitation (MR) do not currently undergo surgery, mainly due to the perceived risk of the procedure (old age, impaired left ventricular function, and comorbidities). Mitral transcatheter interventions carry the hope of minimizing risks while preserving clinical efficacy of surgical repair, as an alternative to conventional treatment. Multiple technologies and diversified approaches are under development with the purpose of treating MR in less invasive ways. They can be categorized based on the anatomical and patho-physiological addressed target. Among them, MitraClip (Abbott Vascular, Inc., Menlo Park, California) has emerged as a clinically safe and effective method for percutaneous mitral valve repair in patients either with degenerative and functional regurgitation. This device mimics the surgical edge-to-edge repair initially described by Alfieri in the early 1990s. Other repair technologies include percutaneous direct and indirect annuloplasty, neochordae implantation, and left ventricular reshaping. They are still in early phase clinical trials or preclinical studies. The combination of different repair techniques is likely to be required to achieve good long-lasting results. In the future, novel devices, improved knowledge, more efficient imaging, and transcatheter mitral prosthetic valve implantation may expand the indications to those patients currently not treated, as well as improve the results both in terms of early efficacy and long-term durability. These treatments are currently reserved to high-risk and inoperable patients, and their application requires an integrated Heart-Team approach. They represent the natural evolution of surgery and promise to expand treatment options and improve patients’ outcomes in the near future.

Mirabel, M., Lung, B., Messika-Zeitoun, D., Detaint, D., Baron, G., Vanoverschelde, J. L., et al. (2007). Severe, symptomatic, mitral regurgitation in the elderly: How many patients are denied surgery and what are their characteristics? Journal of the American College of Cardiology, 49, 300a–300a.

Bursi, F., Enriquez-Sarano, M., Nkomo, V. T., Jacobsen, S. J., Weston, S. A., Meverden, R. A., et al. (2005). Heart failure and death after myocardial infarction in the community—The emerging role of mitral regurgitation. Circulation, 111, 295–301.PubMedCrossRef

Nkomo, V. T., Gardin, J. M., Skelton, T. N., Gottdiener, J. S., Scott, C. G., & Enriquez-Sarano, M. (2006). Burden of valvular heart diseases: A population-based study. Lancet, 368, 1005–1011.PubMedCrossRef

Ling, L. H., EnriquezSarano, M., Seward, J. B., Tajik, A. J., Schaff, H. V., Bailey, K. R., et al. (1996). Clinical outcome of mitral regurgitation due to flail leaflet. New England Journal of Medicine, 335, 1417–1423.PubMedCrossRef

Avierinos, J. F., Gersh, B. J., Melton, L. J., 3rd, Bailey, K. R., Shub, C., Nishimura, R. A., et al. (2002). Natural history of asymptomatic mitral valve prolapse in the community. Circulation, 106, 1355–1361.PubMedCrossRef

Grigioni, F., Enriquez-Sarano, M., Zehr, K. J., Bailey, K. R., & Tajik, A. J. (2001). Ischemic mitral regurgitation: Long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation, 103, 1759–1764.PubMedCrossRef

Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Jr., Faxon, D. P., Freed, M. D., et al. (2006). ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Journal of the American College of Cardiology, 48, e1–e148.PubMedCrossRef

Vahanian, A., Alfieri, O., Andreotti, F., Antunes, M. J., Baron-Esquivias, G., Baumgartner, H., et al. (2012). Guidelines on the management of valvular heart disease (version 2012). European Heart Journal, 33, 2451–2496.PubMedCrossRef

Gammie, J. S., O’Brien, S. M., Zhou, J., Griffith, B. P., Ferguson, T. B., & Peterson, E. D. (2005). Influence of hospital procedural volume on mortality for patients undergoing elective surgery for mitral insufficiency. Circulation, 112, U554–U555.

10.

Detaint, D., Sundt, T. M., Nkomo, V. T., Scott, C. G., Tajik, A. J., Schaff, H. V., et al. (2006). Surgical correction of mitral regurgitation in the elderly: Outcomes and recent improvements. Circulation, 114, 265–272.PubMedCrossRef

11.

Badhwar, V., Peterson, E. D., Jacobs, J. P., He, X., Brennan, J. M., O’Brien, S. M., et al. (2012). Longitudinal outcome of isolated mitral repair in older patients: Results from 14,604 procedures performed from 1991 to 2007. Annals of Thoracic Surgery, 94, 1870–1879.PubMedCrossRef

12.

Lancellotti, P., & Magne, J. (2012). Stress testing for the evaluation of patients with mitral regurgitation. Current Opinion in Cardiology, 27, 492–498.PubMedCrossRef

13.

Hung, J., Papakostas, L., Tahta, S. A., Hardy, B. G., Bollen, B. A., Duran, C. M., et al. (2004). Mechanism of recurrent ischemic mitral regurgitation after annuloplasty—Continued LV remodeling as a moving target. Circulation, 110, Ii85–Ii90.PubMedCrossRef

14.

Wu, A. H., Aaronson, K. D., Bolling, S. F., Pagani, F. D., Welch, K., & Koelling, T. M. (2005). Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. Journal of the American College of Cardiology, 45, 381–387.PubMedCrossRef

15.

Gillinov, A. M., Blackstone, E. H., Rajeswaran, J., Mawad, M., McCarthy, P. M., Sabik, J. F., et al. (2005). Ischemic versus degenerative mitral regurgitation: Does etiology affect survival? Annals of Thoracic Surgery, 80, 811–819.PubMedCrossRef

16.

Mirabel, M., Iung, B., Baron, G., Messika-Zeitoun, D., Detaint, D., Vanoverschelde, J. L., et al. (2007). What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? European Heart Journal, 28, 1358–1365.PubMedCrossRef

17.

Chiam, P. T., & Ruiz, C. E. (2011). Percutaneous transcatheter mitral valve repair: A classification of the technology. JACC. Cardiovascular Interventions, 4, 1–13.PubMedCrossRef

18.

Alfieri, O., Maisano, F., De Bonis, M., Stefano, P. L., Torracca, L., Oppizzi, M., & La Canna, G. (2001). The double-orifice technique in mitral valve repair: A simple solution for complex problems. J Thorac Cardiovasc Surg, 122, 674–681.PubMedCrossRef

19.

Maisano, F., La Canna, G., Colombo, A., & Alfieri, O. (2011). The evolution from surgery to percutaneous mitral valve interventions: The role of the edge-to-edge technique. Journal of the American College of Cardiology, 58, 2174–2182.PubMedCrossRef

20.

Condado, J. A., Acquatella, H., Rodriguez, L., Whitlow, P., Velez-Gimo, M., & St Goar, F. G. (2006). Percutaneous edge-to-edge mitral valve repair: 2-year follow-up in the first human case. Catheterization and Cardiovascular Interventions, 67, 323–325.PubMedCrossRef

21.

Feldman, T., Kar, S., Rinaldi, M., Fail, P., Hermiller, J., Smalling, R., Whitlow, P. L., Gray, W., Low, R., Herrmann, H. C., Lim, S., Foster, E., Glower, D., & Investigators, E. (2009). Percutaneous mitral repair with the mitraclip system safety and midterm durability in the initial everest (endovascular valve edge-to-edge repair study) cohort. Journal of the American College of Cardiology, 54, 686–694.PubMedCrossRef

22.

Feldman, T., Foster, E., Glower, D. D., Kar, S., Rinaldi, M. J., Fail, P. S., et al. (2011). Percutaneous repair or surgery for mitral regurgitation. New England Journal of Medicine, 364, 1395–1406.PubMedCrossRef

23.

George, J. C., Varghese, V., Dangas, G., & Feldman, T. E. (2011). Percutaneous mitral valve repair: Lessons from the Everest II (Endovascular Valve Edge-to-Edge Repair study) and beyond. JACC. Cardiovascular Interventions, 4, 825–827.PubMedCrossRef

24.

Mauri, L., Garg, P., Massaro, J. M., Foster, E., Glower, D., Mehoudar, P., et al. (2010). The Everest II trial: Design and rationale for a randomized study of the Evalve Mitraclip system compared with mitral valve surgery for mitral regurgitation. American Heart Journal, 160, 23–29.PubMedCrossRef

25.

Whitlow, P. L., Feldman, T., Pedersen, W. R., Lim, D. S., Kipperman, R., Smalling, R., et al. (2012). Acute and 12-month results with catheter-based mitral valve leaflet repair: The Everest II (endovascular valve edge-to-edge repair) high risk study. Journal of the American College of Cardiology, 59, 130–139.PubMedCrossRef

26.

Baldus, S., Schillinger, W., Franzen, O., Bekeredjian, R., Sievert, H., Schofer, J., et al. (2012). Mitraclip therapy in daily clinical practice: Initial results from the German Transcatheter Mitral Valve Interventions (TRAMI) registry. European Journal of Heart Failure, 14, 1050–1055.PubMedCrossRef

27.

Maisano, F., Franzen, O., Baldus, S., Hausleiter, J., Butter, C., Schafer, U., et al. (2012). Access Europe: A post market study of the Mitraclip system for the treatment of significant mitral regurgitation (MR) in Europe: Analysis of outcomes at 6-months. Journal of the American College of Cardiology, 59, E2001–E2001.CrossRef

28.

Taramasso, M., Denti, P., Buzzatti, N., De Bonis, M., La Canna, G., Colombo, A., et al. (2012). Mitraclip therapy and surgical mitral repair in patients with moderate to severe left ventricular failure causing functional mitral regurgitation: A single-centre experience. European Journal of Cardio-Thoracic Surgery, 42(6), 920–926. doi:10.1093/ejcts/ezs294.PubMedCrossRef

29.

Seeburger, J., Leontjev, S., Neumuth, M., Noack, T., Hobartner, M., Misfeld, M., et al. (2012). Trans-apical beating-heart implantation of neo-chordae to mitral valve leaflets: Results of an acute animal study. European Journal of Cardio-Thoracic Surgery, 41, 173–176. discussion 176.PubMedCrossRefPubMedCentral

30.

Seeburger, J., Rinaldi, M., Nielsen, S. L., Salizione, S., Lange, R., Schoenburg, M., et al. (2013). Off pump transapical implantation of artificial chordae to correct mitral regurgitation (tact trial)—Proof of concept. Journal of the American College of Cardiology, 2(6), 758–764.

31.

Maisano, F., Cioni, M., Seeburger, J., Falk, V., Mohr, F. W., Mack, M. J., et al. (2011). Beating-heart implantation of adjustable length mitral valve chordae: Acute and chronic experience in an animal model. European Journal of Cardio-Thoracic Surgery, 40, 840–847.PubMed

32.

Panic, G., Ristic, M., Putnik, S., Markovic, D., Divac, I., & Babic, U. U. (2009). A novel technique for treatment of mitral valve prolapse/flail. Journal of Thoracic and Cardiovascular Surgery, 137, 1568–1570.PubMedCrossRef

33.

Williams, J. L., Toyoda, Y., Ota, T., Gutkin, D., Katz, W., Zenati, M., et al. (2008). Feasibility of myxomatous mitral valve repair using direct leaflet and chordal radiofrequency ablation. Journal of Interventional Cardiology, 21, 547–554.PubMedCrossRefPubMedCentral

34.

Carpentier, A. (1983). Cardiac valve surgery—The “French correction”. Journal of Thoracic and Cardiovascular Surgery, 86, 323–337.PubMed

35.

Bolling, S. F., Deeb, G. M., Brunsting, L. A., & Bach, D. S. (1995). Early outcome of mitral valve reconstruction in patients with end-stage cardiomyopathy. Journal of Thoracic and Cardiovascular Surgery, 109, 676–682. discussion 682–673.PubMedCrossRef

36.

Timek, T. A., Nielsen, S. L., Lai, D. T., Tibayan, F. A., Liang, D., Rodriguez, F., et al. (2003). Edge-to-edge mitral valve repair without ring annuloplasty for acute ischemic mitral regurgitation. Circulation, 108, 122–127.CrossRef

37.

Grayburn, P. A., Roberts, B. J., Aston, S., Anwar, A., Hebeler, R. F., Jr., Brown, D. L., et al. (2011). Mechanism and severity of mitral regurgitation by transesophageal echocardiography in patients referred for percutaneous valve repair. American Journal of Cardiology, 108, 882–887.PubMedCrossRef

38.

Tibayan, F. A., Rodriguez, F., Langer, F., Zasio, M. K., Bailey, L., Liang, D., et al. (2004). Does septal–lateral annular cinching work for chronic ischemic mitral regurgitation? Journal of Thoracic and Cardiovascular Surgery, 127, 654–663.PubMedCrossRef

39.

Palacios, I. F., Condado, J. A., Brandi, S., Rodriguez, V., Bosch, F., Silva, G., et al. (2007). Safety and feasibility of acute percutaneous septal sinus shortening: First-in-human experience. Catheterization and Cardiovascular Interventions, 69, 513–518.PubMedCrossRef

40.

Rogers, J. H., Rahdert, D. A., Caputo, G. R., Takeda, P. A., Palacios, I. F., Tio, F. O., et al. (2009). Long-term safety and durability of percutaneous septal sinus shortening (the PS(3) system) in an ovine model. Catheterization and Cardiovascular Interventions, 73, 540–548.PubMedCrossRef

41.

Grossi, E. A., Patel, N., Woo, Y. J., Goldberg, J. D., Schwartz, C. F., Subramanian, V., et al. (2010). Outcomes of the RESTOR-MV trial (Randomized Evaluation of a Surgical Treatment for Off-Pump Repair of the Mitral Valve). Journal of the American College of Cardiology, 56, 1984–1993.PubMedCrossRef

42.

Carrick, R., Ge, L., Lee, L. C., Zhang, Z., Mishra, R., Axel, L., et al. (2012). Patient-specific finite element-based analysis of ventricular myofiber stress after coapsys: Importance of residual stress. Annals of Thoracic Surgery, 93, 1964–1971.PubMedCrossRefPubMedCentral

43.

Pedersen, W. R., Block, P., Leon, M., Kramer, P., Kapadia, S., Babaliaros, V., et al. (2008). Icoapsys mitral valve repair system: Percutaneous implantation in an animal model. Catheterization and Cardiovascular Interventions, 72, 125–131.PubMedCrossRef

44.

Raman, J., Hare, D., Storer, M., & Hata, M. (2009). Epicardial cardiac basal annuloplasty: Preliminary findings on extra-cardiac mitral valve repair. Heart Lung and Circulation, 18, 401–406.CrossRef

45.

Raman, J., Jagannathan, R., Chandrashekar, P., & Sugeng, L. (2011). Can we repair the mitral valve from outside the heart? A novel extra-cardiac approach to functional mitral regurgitation. Heart Lung and Circulation, 20, 157–162.CrossRef

46.

Harnek, J., Webb, J. G., Kuck, K. H., Tschope, C., Vahanian, A., Buller, C. E., et al. (2011). Transcatheter implantation of the MONARC coronary sinus device for mitral regurgitation: 1-year results from the evolution phase I study (clinical evaluation of the Edwards Lifesciences percutaneous mitral annuloplasty system for the treatment of mitral regurgitation). JACC. Cardiovascular Interventions, 4, 115–122.PubMedCrossRef

47.

Siminiak, T., Wu, J. C., Haude, M., Hoppe, U. C., Sadowski, J., Lipiecki, J., et al. (2012). Treatment of functional mitral regurgitation by percutaneous annuloplasty: Results of the titan trial. European Journal of Heart Failure, 14, 931–938.PubMedCrossRefPubMedCentral

48.

Sack, S. (2009). Percutaneous mitral annuloplasty with the VIACOR (TM) coronary sinus system for the treatment of functional mitral regurgitation in heart failure patients. Development and Results Herz, 34, 468–476.CrossRef

49.

Schofer, J., Siminiak, T., Haude, M., Herrman, J. P., Vainer, J., Wu, J. C., et al. (2009). Percutaneous mitral annuloplasty for functional mitral regurgitation results of the carillon mitral annuloplasty device European Union study. Circulation, 120, 326–333.PubMedCrossRefPubMedCentral

50.

Noble, S., Vilarino, R., Muller, H., Sunthorn, H., & Roffi, M. (2011). Fatal coronary sinus and aortic erosions following percutaneous transvenous mitral annuloplasty device. EuroIntervention: Journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 7, 148–150.CrossRef

51.

Machaalany, J., St-Pierre, A., Senechal, M., Larose, E., Philippon, F., Abdelaal, E., et al. (2013). Fatal late migration of VIACOR percutaneous transvenous mitral annuloplasty device resulting in distal coronary venous perforation. Canadian Journal of Cardiology, 29(130), e131–e134.

52.

Kim, J. H., Kocaturk, O., Ozturk, C., Faranesh, A. Z., Sonmez, M., Sampath, S., et al. (2009). Mitral cerclage annuloplasty, a novel transcatheter treatment for secondary mitral valve regurgitation initial results in swine. Journal of the American College of Cardiology, 54, 638–651.PubMedCrossRefPubMedCentral

53.

Maselli, D., Guarracino, F., Chiaramonti, F., Mangia, F., Borelli, G., & Minzioni, G. (2006). Percutaneous mitral annuloplasty: An anatomic study of human coronary sinus and its relation with mitral valve annulus and coronary arteries. Circulation, 114, 377–380.PubMedCrossRef

54.

Choure, A. J., Garcia, M. J., Hesse, B., Sevensma, M., Maly, G., Greenberg, N. L., et al. (2006). In vivo analysis of the anatomical relationship of coronary sinus to mitral annulus and left circumflex coronary artery using cardiac multidetector computed tomography—Implications for percutaneous coronary sinus mitral annuloplasty. Journal of the American College of Cardiology, 48, 1938–1945.PubMedCrossRef

55.

Lansac, E., Di Centa, I., Al Attar, N., Messika-Zeitoun, D., Raffoul, R., Vahanian, A., et al. (2008). Percutaneous mitral annuloplasty through the coronary sinus: An anatomic point of view. Journal of Thoracic and Cardiovascular Surgery, 135, 376–381.PubMedCrossRef

56.

Tops, L. F., van de Veire, N. R., Schuijf, J. D., van der Wall, E. E., Schalij, M. J., & Bax, J. J. (2007). Non-invasive evaluation of coronary sinus anatomy and its relation to the mitral valve annulus: Implications for percutaneous mitral annuloplasty. Journal of the American College of Cardiology, 49, 299a–299a.

57.

Spoor, M. T., Geltz, A., & Bolling, S. F. (2006). Flexible versus nonflexible mitral valve rings for congestive heart failure—Differential durability of repair. Circulation, 114, I67–I71.PubMedCrossRef

58.

Maisano, F., Vanermen, H., Seeburger, J., Mack, M., Falk, V., Denti, P., et al. (2012). Direct access transcatheter mitral annuloplasty with a sutureless and adjustable device: Preclinical experience. European Journal of Cardio-Thoracic Surgery, 42, 524–529.PubMedCrossRef

59.

Kwon, M. H., Lee, L. S., Cevasco, M., Couper, G. S., Shekar, P. S., Cohn, L. H., et al. (2012). Recurrence of mitral regurgitation after partial versus complete mitral valve ring annuloplasty for functional mitral regurgitation. Journal of Thoracic and Cardiovascular Surgery, 94(4), 1211–1216.

60.

Goel, R., Witzel, T., Dickens, D., Takeda, P. A., & Heuser, R. R. (2009). The quantum core device for treating mitral regurgitation: An animal study. Catheterization and Cardiovascular Interventions, 74, 43–48.PubMedCrossRef

61.

Rahman, S., Eid, N., Murarka, S., & Heuser, R. R. (2010). Remodeling of the mitral valve using radiofrequency energy: Review of a new treatment modality for mitral regurgitation. Cardiovascular Revascularization Medicine, 11, 249–259.PubMedCrossRef

62.

Jilaihawi, H., Virmani, R., Nakagawa, H., Ducharme, A., Shi, Y. F., Carter-Monroe, N., et al. (2010). Mitral annular reduction with subablative therapeutic ultrasound: Pre-clinical evaluation of the Recor device. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 6, 54–62.CrossRef

63.

Minha, S., Torguson, R., & Waksman, R. (2013). Overview of the 2013 Food and Drug Administration circulatory system devices panel meeting on the Mitraclip delivery system. Circulation, 128, 864–868.PubMedCrossRef

64.

Montorfano, M., Latib, A., Chieffo, A., Moshiri, S., Franco, A., Grimaldi, A., et al. (2011). Successful percutaneous anterograde transcatheter valve-in-valve implantation in the mitral position. JACC. Cardiovascular Interventions, 4, 1246–1247.PubMedCrossRef

65.

Kliger, C., Eiros, R., Isasti, G., Einhorn, B., Jelnin, V., Cohen, H., et al. (2013). Review of surgical prosthetic paravalvular leaks: Diagnosis and catheter-based closure. European Heart Journal, 34, 638–649.PubMedCrossRef

66.

Schillinger, W., Hunlich, M., Baldus, S., Ouarrak, T., Boekstegers, P., Hink, U., et al. (2013). Acute outcomes after Mitraclip therapy in highly aged patients: Results from the German Transcatheter Mitral Valve Interventions (TRAMI) registry. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 9, 84–90.CrossRef

67.

Sondergaard, L. (2012). Transcatheter mitral valve implantation: Cardiaq. TCT Meeting, Miami.

68.

Iino, K., Boldt, J., Lozonschi, L., Metzner, A., Schoettler, J., Petzina, R., et al. (2012). Off-pump transapical mitral valve replacement: Evaluation after one month. European Journal of Cardio-Thoracic Surgery, 41, 512–517.PubMedCrossRef

69.

Maisano, F. (2013). Percutaneous cardiovalve percutaneous mitral valve replacement system. EuroPCR Meeting, Paris

70.

Banai, S., Jolicoeur, E. M., Schwartz, M., Garceau, P., Biner, S., Tanguay, J. F., et al. (2012). A novel catheter-based mitral valve bioprosthesis: Initial experiments and short-term pre-clinical results. Journal of the American College of Cardiology, 60(15), 1430–1431. doi:10.1016/j.jacc.2012.05.047.PubMedCrossRef

71.

Ma, L., Tozzi, P., Huber, C. H., Taub, S., Gerelle, G., & von Segesser, L. K. (2005). Double-crowned valved stents for off-pump mitral valve replacement. European Journal of Cardio-Thoracic Surgery, 28, 194–198.PubMedCrossRef

Title: Devices for Mitral Valve Repair
Authors: Paolo Denti
Francesco Maisano
Ottavio Alfieri
Publication date: 01-04-2014
Publisher: Springer US
Published in: Journal of Cardiovascular Translational Research / Issue 3/2014
Print ISSN: 1937-5387
Electronic ISSN: 1937-5395
DOI: https://doi.org/10.1007/s12265-014-9543-y

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Devices for Mitral Valve Repair

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2014

The Baroreceptor as a Therapeutic Target for Heart Failure

Left Ventricular Restoration Devices

Left Cardiac Sympathetic Denervation in Patients with Heart Failure: a New Indication for an Old Intervention?

Novel Non-pharmacological Approaches to Heart Failure

Is There a Need for Bacterial Endocarditis Prophylaxis in Patients Undergoing Urological Procedures?

Distinguishing Hypertrophic Cardiomyopathy-Associated Mutations from Background Genetic Noise

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page